Higher BMI may be linked with worse survival among SBS88 positive CRC patients
Higher BMI may be linked with worse survival among SBS88 positive CRC patients
MatchMiner: An open-source AI precision medicine trial matching platform
Test identifies tumour-infiltrating cell densities as prognostic biomarkers across a pan-cancer cohort
Indications for the appropriate use of a PET-CT scan for common cancers
Choosing Wisely in neoadjuvant treatment for different cancers in the Philippines
The role of CDK4/6 inhibitors in the treatment of metastatic breast cancer
Current indications and challenges with IORT in the Philippines
A multidisciplinary team approach to cancer care in the Philippines
Choosing the right serum and molecular biomarkers in the Philippines
Amivantamab shows robust efficacy in post-platinum therapy patients with EGFR Ex20ins NSCLC
Neoadjuvant nivolumab plus chemotherapy continues to provide long-term clinical benefit in patients with resectable NSCLC
Four chemo cycles given with durvalumab and tremelimumab optimise response and tumour shrinkage in patients with mNSCLC